European healthcare-focused private equity firm managing €9 billion
ARCHIMED is a healthcare-exclusive PE firm with offices across Europe, North America, and APAC, managing one of Europe's largest dedicated healthcare funds. The hiring mix—dominated by finance and sales roles with notable C-suite additions (Chief Commercial Officer, Chief Information Officer)—alongside active projects in fundraising strategy, co-investment programs, and IT/digital transformation reflects a firm in growth and operational modernization. Pain points around global investor network expansion, compliance, and cost-effective IT signal ongoing scaling challenges typical of PE firms moving beyond their home market.
Notable leadership hires: Chief Information Officer, Chief Commercial Officer
ARCHIMED invests exclusively in healthcare, with deep focus on biopharma, MedTech, diagnostics, consumer health, life science tools, and related services. Founded in 2014 and headquartered in Lyon, the firm partners with healthcare businesses on internationalization, M&A, product innovation, and market expansion. The team blends operational, medical, scientific, and financial expertise. Beyond capital deployment, ARCHIMED has committed to impact investing directly and through its EURÊKA Foundation. Current headcount sits between 51–200 employees across multiple geographies.
ARCHIMED invests exclusively in healthcare across eight core areas: biopharma products, consumer health, animal & environmental health, healthcare IT, diagnostics, life science tools & biologic services, MedTech, and pharma services.
ARCHIMED manages €9 billion across its fund portfolio, including the largest healthcare-only private equity fund raised by a European-based general partner.
Other companies in the same industry, closest in size